Skip to main content
Xcell Therapeutics Inc. logo

Xcell Therapeutics Inc. — Investor Relations & Filings

Ticker · 373110 ISIN · KR7373110006 KO Manufacturing
Filings indexed 86 across all filing types
Latest filing 2026-05-15 Annual Report
Country KR South Korea
Listing KO 373110

About Xcell Therapeutics Inc.

https://www.xcell.co.kr/

Xcell Therapeutics Inc. is a company specializing in the research, development, and production of advanced cell culture media. Its primary product line, CellCor™, consists of serum-free, chemically defined media designed to provide an optimal environment for cell culture, particularly for mesenchymal stem cells (MSCs). The technology aims to enhance efficiency and yield for researchers and developers in the fields of cell therapy and regenerative medicine. By offering a serum-free alternative, the company provides a more consistent and defined solution compared to traditional media. Xcell Therapeutics is also expanding its services to become a Contract Development and Manufacturing Organization (CDMO) and is exploring applications for its media in the cultured meat sector.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 98% confidence The document is a comprehensive statutory business report (‘사업보고서’) for the fiscal year ending December 31, 2025, including company overview, corrected financial statements, management and governance details, and full financial performance data. It is clearly the full annual report itself (over 200,000 characters) rather than an announcement or summary. This aligns with the definition of an Annual Report (10-K). FY 2025
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive quarterly report (“분기보고서”) covering the period January 1 to March 31, 2026, and includes detailed financial statements, business overview, operational data, sales figures, production capacity, R&D details, and other substantive financial and narrative content. It is not merely an announcement of a report or an officer certification—it contains actual financial data and analysis. This falls squarely under an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is a notice titled “기업설명회(IR) 개최” by 엑셀세라퓨틱스, providing detailed logistics for an upcoming investor relations event (date/time, location, audience, agenda, materials posting). This falls under the “Investor Presentation” category rather than an earnings release or annual/interim report. Hence it is classified as an Investor Presentation (IP).
2026-04-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a statutory insider disclosure filed by a company director (임원) reporting the number of shares and other securities owned, detailing changes in shareholdings and transaction dates. This matches a director’s dealing report disclosing personal transactions in company shares. Therefore, it is classified as DIRS.
2026-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a regulatory report filed with the Korean Securities & Futures Commission and Korea Exchange disclosing an officer’s (임원) holdings and changes in ownership of the company’s shares. It details acquisition dates, share counts, and transaction prices by a company officer (Oh Soo Lim). This matches the definition for Director’s Dealing (insider share transactions).
2026-04-01 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean “주식등의 대량보유상황보고서 (일반)” which translates to a large shareholding status report (amended). This is a mandatory disclosure when an investor’s equity holdings cross statutory thresholds, akin to a ‘Major Shareholding Notification’. It details share counts, holding percentages, related parties, and changes. Therefore, it falls under the Major Shareholding Notification category (Code: MRQ).
2026-04-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.